Skip to main content
ZBIO
NASDAQ Life Sciences

Zenas Posts $647M Cash, EMA Validates Obexelimab MAA Ahead of May 2027 PDUFA

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$28.46
Mkt Cap
$1.855B
52W Low
$13.5
52W High
$44.6
52W Position info
111% above low
Off High info
36% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

ZBIO has more than doubled off its 52-week low of $13.5.

Summary

Zenas ended Q3 with $647.1 million in cash, cash equivalents and investments, down from $673.9 million at mid-year as R&D and pre-commercial spending ramped. The EMA validated the obexelimab MAA for IgG4-RD, adding a second regulatory track alongside the FDA BLA accepted in August with a PDUFA date of May 27, 2027. Revenue was $10.0 million from a Bristol Myers Squibb development milestone, but the net loss widened to $108.9 million ($1.65 per share) from $51.5 million a year ago on higher R&D ($58.5M), G&A ($27.4M) and $27.5 million of acquired IPR&D tied to InnoCare and Xencor milestones. Management says cash funds operations at least through Q2 2029, assuming a $75 million Royalty Pharma milestone and $75 million drawn from the Pharmakon debt facility on FDA approval. Two near-term readouts matter most: Phase 2 SunStone topline in SLE and initial Phase 1 ZB021 data, both expected in Q4 2026.

At the time of this announcement, ZBIO was trading at $28.46 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $13.50 to $44.60. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

ZBIO - Latest Insights

ZBIO
Nov 05, 2026, 7:19 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $28.46
Real-time Price: $25.04 info
Change: -$3.42 (-12%) info
Market Cap: $1.698B info
ZBIO
Oct 13, 2026, 6:01 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $26.40
Real-time Price: $25.04 info
Change: -$1.36 (-5%) info
Market Cap: $1.698B info
ZBIO
Aug 19, 2026, 4:15 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $31.04
Real-time Price: $25.04 info
Change: -$6.00 (-19%) info
Market Cap: $1.698B info
ZBIO
Aug 13, 2026, 7:15 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $31.30
Real-time Price: $25.04 info
Change: -$6.26 (-20%) info
Market Cap: $1.698B info
ZBIO
Aug 13, 2026, 7:05 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $31.30
Real-time Price: $25.04 info
Change: -$6.26 (-20%) info
Market Cap: $1.698B info